<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">molecules</journal-id>
      <journal-title>Molecules</journal-title>
      <abbrev-journal-title abbrev-type="publisher">Molecules</abbrev-journal-title>
      <abbrev-journal-title abbrev-type="pubmed">Molecules</abbrev-journal-title>
      <issn pub-type="epub">1420-3049</issn>
      <publisher>
        <publisher-name>MDPI</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.3390/10111399</article-id>
      <article-id pub-id-type="publisher-id">molecules-10-01399</article-id>
	  <article-categories>
        <subj-group>
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Synthesis, Reactivity and Biological Activity of Novel Bisbenzofuran-2-yl-Methanone Derivatives</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Kirilmis</surname>
            <given-names>Cumhur</given-names>
          </name>
          <xref rid="af1-molecules-10-01399" ref-type="aff">1</xref>
		  </contrib>
		  <contrib contrib-type="author">
          <name>
            <surname>Koca</surname>
            <given-names>Murat</given-names>
          </name>
          <xref rid="af1-molecules-10-01399" ref-type="aff">1</xref>
		  </contrib>
		  <contrib contrib-type="author">
          <name>
            <surname>&#xC7;ukurovali</surname>
            <given-names>Alaaddin</given-names>
          </name>
          <xref rid="af1-molecules-10-01399" ref-type="aff">1</xref>
		  <xref rid="c1-molecules-10-01399" ref-type="corresp">*</xref>
		  </contrib>
		  <contrib contrib-type="author">
          <name>
            <surname>Ahmedzade</surname>
            <given-names>Misir</given-names>
          </name>
          <xref rid="af1-molecules-10-01399" ref-type="aff">1</xref>
		  </contrib>
		  <contrib contrib-type="author">
          <name>
            <surname>Kazaz</surname>
            <given-names>Cavit</given-names>
          </name>
          <xref rid="af2-molecules-10-01399" ref-type="aff">2</xref>
		  </contrib>
      </contrib-group>
      <aff id="af1-molecules-10-01399"><label>1</label>Department of Chemistry, Faculty of Arts and Sciences, Firat University, 23119 Elazig, Turkey</aff>
      <aff id="af2-molecules-10-01399"><label>2</label>Department of Chemistry, Faculty of Arts and Sciences, Ataturk University, 25240 Erzurum, Turkey</aff>
      <author-notes>
        <corresp id="c1-molecules-10-01399"><label>*</label>Author to whom correspondence should be addressed; e-mail: <email>acukurovali@firat.edu.tr</email></corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>30</day>
        <month>11</month>
        <year>2005</year>
      </pub-date>
      <pub-date pub-type="collection">
        <month>11</month>
        <year>2005</year>
      </pub-date>
      <volume>10</volume>
      <issue>11</issue>
      <fpage>1399</fpage>
      <lpage>1408</lpage>
      <history>
        <date date-type="received">
          <day>04</day>
          <month>08</month>
          <year>2005</year>
        </date>
        <date date-type="rev-recd">
          <day>11</day>
          <month>10</month>
          <year>2005</year>
        </date>
        <date date-type="accepted">
          <day>15</day>
          <month>10</month>
          <year>2005</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2005 by MDPI (http:www.mdpi.org).</copyright-statement>
        <copyright-year>2005</copyright-year>
        <license license-type="open-access">
          <p>Reproduction is permitted for noncommercial purposes.</p>
        </license>
      </permissions>
      <abstract>
        <p>Preparation of bisbenzofuran-2-yl-methanone (<bold>1</bold>), the corresponding ketoxime <bold>4</bold>, semicarbazone and thiosemicarbazone <bold>3a</bold> and <bold>3b</bold>, ether derivatives of the ketoximes <bold>5a-j</bold> and the alcohol <bold>2</bold> are described. These substances have been prepared in excellent yields. All the synthesized compounds except <bold>5i</bold> have been tested against five different microorganisms and some of them were found to be active against some of the species studied.</p>
      </abstract>
      <kwd-group>
        <kwd>Bisbenzofuran</kwd>
		<kwd>(thio)semicarbazone</kwd>
		<kwd>oxime</kwd>
		<kwd>oxime ethers dervatives</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>Introduction</title>
      <p>After the discovery of disodium cromoglycate (DSCG), an eficient drug which is useful in treatment of human asthma, several isosteric or structurally related bisheterocyclic systems have been synthesized [<xref ref-type="bibr" rid="B1-molecules-10-01399">1</xref>,<xref ref-type="bibr" rid="B2-molecules-10-01399">2</xref>,<xref ref-type="bibr" rid="B3-molecules-10-01399">3</xref>]. DSCG-like and bisbenzofuran containing structures have been synthesized and characterized by Sunder and Peet [<xref ref-type="bibr" rid="B4-molecules-10-01399">4</xref>]. The condensation products of quinine that incorporate the structures of the 2,8-dimethoxydibenzofuran dimer, the trimer, 2,11-dimethoxybenzo-[1,2-b;3,4-b&#x2019;]bis(benzofuran) [<xref ref-type="bibr" rid="B5-molecules-10-01399">5</xref>], and the open tetramer dibenzo[b,b&#x2019;]furo[3,2-e;4,5-e&#x2019;]bis(benzofuran) derivatives [<xref ref-type="bibr" rid="B6-molecules-10-01399">6</xref>] have been synthesized and their X-ray crystal structures have been clarified, but overall there is limited literature on bisbenzofuran itself and bisbenzofuran containing compounds. According to our literature survey, no reports concerning oxime ether containing bisbenzofuran rings have been published since 1970. On the other hand, limited biological activity studies on bis- benzofuran containing compounds were found [<xref ref-type="bibr" rid="B3-molecules-10-01399">3</xref>,<xref ref-type="bibr" rid="B5-molecules-10-01399">5</xref>,<xref ref-type="bibr" rid="B7-molecules-10-01399">7</xref>]. As is known, oxime ethers have found many uses in recent years as nonsteroidal antinflammatory drugs [<xref ref-type="bibr" rid="B8-molecules-10-01399">8</xref>], beta-adrenergic [<xref ref-type="bibr" rid="B9-molecules-10-01399">9</xref>], mold inhibitory active compound in poultry science [<xref ref-type="bibr" rid="B10-molecules-10-01399">10</xref>], anti-protozoan [<xref ref-type="bibr" rid="B11-molecules-10-01399">11</xref>], insect growth regulator [<xref ref-type="bibr" rid="B12-molecules-10-01399">12</xref>] and as various materials with steroidal effects [<xref ref-type="bibr" rid="B13-molecules-10-01399">13</xref>].</p>
      <p>The present investigation was performed for the purpose of synthesizing bisbenzofuran containing methanones and their derivatives. All these derivatives except <bold>5a</bold> and <bold>5b</bold> have active sites which easily reacts with some other compounds to form new structures. As far as we know this is the first report on these substances.</p>
      <fig id="molecules-10-01399-f001" position="float">
        <object-id pub-id-type="pii">molecules-10-01399-scheme1_Scheme 1</object-id>
        <label>Scheme 1</label>
        <caption>
          <p>Reaction sequence for the synthesis of compounds</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molecules-10-01399-g001.tif"/>
      </fig>
    </sec>
    <sec sec-type="results">
      <title>Results and Discussion</title>
      <p>Bisbenzofuran-2-yl-methanone (<bold>1</bold>) was synthesized in two different ways. The synthetic routes followed are shown in <xref ref-type="scheme" rid="molecules-10-01399-f001">Scheme <bold>1</bold></xref>. Overall yields of both routes are good and more or less similar. A is a new route, while B is the literature method [<xref ref-type="bibr" rid="B14-molecules-10-01399">14</xref>]. 1-(Benzofuran-2-yl)-2-bromoethanone, which is the starting material for method A, was synthesized from benzaldehyde and 1&#x2011;bromoacetone, followed by subsequent bromination with bromine in acetic acid, according to the general procedure described in [<xref ref-type="bibr" rid="B14-molecules-10-01399">14</xref>] with slight modifications. Treatment of this compound with salicylaldehyde in acetone solution gave bisbenzofuran-2-yl-methanone (<bold>1</bold>) in the presence of NaH as neutralizing base. Since the synthesis of only one compound can result in the synthesis of bis-benzofuran-2-yl-methanone (<bold>1</bold>) by route A, time consuming separation processes, for example chromatography, are not necessary. On the other hand, this new route is also provided slightly higher yield of compound (<bold>1</bold>). For method B, the literature procedure was followed.</p>
      <p>The reactions involve a nucleophilic substitution reaction in acetone between 1&#x2011;bromoacetone or 1,3-dichloroacetone and the sodium salts of 2-hydroxy-benzaldehyde (<xref ref-type="scheme" rid="molecules-10-01399-f001">Scheme 1</xref>). As a result of: (i) the strong nucleophilicity of the sodium salts of aldehydes, (ii) the absence of steric hindrance by dichloroacetone or 1-bromoacetylbenzofuran and (iii) the increased positive charge of the positive center of the carbocation formed by the elimination of chloride or bromide from the latter, due to the inductive effect of chlorine or bromine atoms, the acetone solvent provides a relatively mild temperature conditions for the formation of the expected substances with excellent yields.</p>
      <p>The first compound, bisbenzofuran-2-yl-methanone (<bold>1</bold>), was prepared in the presence of potassium carbonate in excellent yields (81.9% by method B and 84.2% by method A). The disappearance of &#x2011;CH<sub>2</sub>&#x2011;Cl or &#x2011;CH<sub>2</sub>&#x2011;Br, (C=O, aldehyde) and -OH stretching bands of starting substances at about 732, 748, 1667 and 3319 cm<sup>&#x2013;1</sup>, respectively, are evidence for the formation of the desired substance. Besides, the <sup>1</sup>H-NMR spectra of the compound showed only aromatic protons. In the second step, <bold>1</bold> was reduced to its alcohol derivative <bold>2</bold> in the presence of NaBH<sub>4</sub> in dioxane. The disappearance of the ketone C=O band and detection of a strong -OH band at about 3330 cm<sup>&#x2013;1</sup>, are evidence for the formation of the alcohol derivative <bold>2</bold>. In the <sup>1</sup>H-NMR spectra of this compound, the &#x2013;OH proton appears at 6.11 ppm. Treatment of <bold>1</bold> with semicarbazide or thiosemicarbazide in ethanol resulted in the formation of the semicarbazone  and thiosemicarbazone derivatives <bold>3a</bold> and <bold>3b</bold>, respectively. Reaction of <bold>1</bold> with NH<sub>2</sub>OH&#x387;HCl in pyridine gave its oxime derivative <bold>4</bold>. The absence of the C=O band of <bold>1</bold> and the existence of a broad =N-OH band ceneterd around 3166 cm<sup>-1</sup> in the IR spectra of <bold>4</bold>, confirm the formation of the compound. The oxime &#x2013;OH proton appears as a broad singlet at 13.01 ppm in the corresponding <sup>1</sup>H-NMR spectrum. </p>
      <p>Reactions of <bold>4</bold> in acetone with appropriate alkyl iodides or bromides, or acyl chlorides in the presence of K<sub>2</sub>CO<sub>3</sub>, gave the oxime ether type compounds <bold>5a-j</bold>. The use of acetone as solvent provides relatively mild temperature conditions for the formation of the expected substances in excellent yields. The analytical and spectroscopic characterization data of the compounds <bold>5a-j</bold> given in the Experimental are in good agreement with the expected structures&#x2019; characteristics, as are the elemental analysis results. All the compounds synthesized here are solid substances, stable at room temperature and not affected by atmospheric conditions over at least in two weeks. On the other hand, as these compounds contain benzofuran, epoxide, ester, alkyl chloride, carbazone and hydrazide functions in their molecules, they seem to be suitable candidates for further chemical modifications and may be pharmacologically active and useful as ligands in coordination chemistry.</p>
      <p>The compounds, except <bold>5i</bold>, were tested against two gram&#x2013;positive (<italic>Staphylococcus aureus</italic> COWAN I, <italic>Bacillus megaterium</italic> DSM 32) and two gram&#x2013;negative bacteria (<italic>Klebsiella pneumonia</italic> FMC 5, <italic>Escherichia coli</italic> ATCC 25922). The antifungal activiti<italic>e</italic>s of compounds were evaluated <italic>in vitro</italic> against a yeast&#x2013;like fungus such as <italic>Candida albicans</italic> CCM 314. The test results obtained are listed in <xref ref-type="table" rid="molecules-10-01399-t001">Table 1</xref>. Antifungal and antibacterial data for streptomycin and nystatin are also included in this Table for comparison purposes. The data show that these compounds generally exhibited moderate activity at the higher concentrations towards many of the bacteria and the fungus tested. The most active compound is <bold>1</bold>. This compound exhibited activity towards all the microorganisms studied. Unexpectedly, six of the substances tested showed no toxicity any of the bacteria and the yeast under the test conditions. Studies of the biological activity of the substances towards some other different bacteria and yeasts are in progress.</p>
      <table-wrap id="molecules-10-01399-t001" position="float">
        <object-id pub-id-type="pii">molecules-10-01399-t001_Table 1</object-id>
        <label>Table 1</label>
        <caption>
          <p>Antimicrobial effect of the compounds*</p>
        </caption>
        <table>
          <thead>
            <tr>
              <th align="center" valign="middle">Compound</th>
              <th align="center" valign="middle"><italic>S. aureus</italic></th>
              <th align="center" valign="middle"><italic>B. megaterium</italic></th>
              <th align="center" valign="middle"><italic>K. pneumonia</italic></th>
              <th align="center" valign="middle"><italic>E. coli</italic></th>
              <th align="center" valign="middle"><italic>C. albicans</italic></th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="center" valign="middle"><bold>1</bold></td>
              <td align="center" valign="middle">13</td>
              <td align="center" valign="middle">18</td>
              <td align="center" valign="middle">15</td>
              <td align="center" valign="middle">18</td>
              <td align="center" valign="middle">17</td>
            </tr>
            <tr>
              <td align="center" valign="middle"><bold>2</bold></td>
              <td align="center" valign="middle">-</td>
              <td align="center" valign="middle">15</td>
              <td align="center" valign="middle">13</td>
              <td align="center" valign="middle">-</td>
              <td align="center" valign="middle">-</td>
            </tr>
            <tr>
              <td align="center" valign="middle"><bold>3a</bold></td>
              <td align="center" valign="middle">-</td>
              <td align="center" valign="middle">-</td>
              <td align="center" valign="middle">-</td>
              <td align="center" valign="middle">-</td>
              <td align="center" valign="middle">-</td>
            </tr>
            <tr>
              <td align="center" valign="middle"><bold>3b</bold></td>
              <td align="center" valign="middle">-</td>
              <td align="center" valign="middle">-</td>
              <td align="center" valign="middle">-</td>
              <td align="center" valign="middle">-</td>
              <td align="center" valign="middle">-</td>
            </tr>
            <tr>
              <td align="center" valign="middle"><bold>4</bold></td>
              <td align="center" valign="middle">8</td>
              <td align="center" valign="middle">13</td>
              <td align="center" valign="middle">11</td>
              <td align="center" valign="middle">14</td>
              <td align="center" valign="middle">12</td>
            </tr>
            <tr>
              <td align="center" valign="middle"><bold>5a</bold></td>
              <td align="center" valign="middle">9</td>
              <td align="center" valign="middle">11</td>
              <td align="center" valign="middle">11</td>
              <td align="center" valign="middle">-</td>
              <td align="center" valign="middle">15</td>
            </tr>
            <tr>
              <td align="center" valign="middle"><bold>5b</bold></td>
              <td align="center" valign="middle">-</td>
              <td align="center" valign="middle">-</td>
              <td align="center" valign="middle">-</td>
              <td align="center" valign="middle">-</td>
              <td align="center" valign="middle">-</td>
            </tr>
            <tr>
              <td align="center" valign="middle"><bold>5c</bold></td>
              <td align="center" valign="middle">-</td>
              <td align="center" valign="middle">-</td>
              <td align="center" valign="middle">-</td>
              <td align="center" valign="middle">-</td>
              <td align="center" valign="middle">-</td>
            </tr>
            <tr>
              <td align="center" valign="middle"><bold>5d</bold></td>
              <td align="center" valign="middle">-</td>
              <td align="center" valign="middle">-</td>
              <td align="center" valign="middle">-</td>
              <td align="center" valign="middle">-</td>
              <td align="center" valign="middle">-</td>
            </tr>
            <tr>
              <td align="center" valign="middle"><bold>5e</bold></td>
              <td align="center" valign="middle">-</td>
              <td align="center" valign="middle">8</td>
              <td align="center" valign="middle">-</td>
              <td align="center" valign="middle">-</td>
              <td align="center" valign="middle">-</td>
            </tr>
            <tr>
              <td align="center" valign="middle"><bold>5f</bold></td>
              <td align="center" valign="middle">13</td>
              <td align="center" valign="middle">15</td>
              <td align="center" valign="middle">13</td>
              <td align="center" valign="middle">11</td>
              <td align="center" valign="middle">-</td>
            </tr>
            <tr>
              <td align="center" valign="middle"><bold>5g</bold></td>
              <td align="center" valign="middle">15</td>
              <td align="center" valign="middle">18</td>
              <td align="center" valign="middle">18</td>
              <td align="center" valign="middle">13</td>
              <td align="center" valign="middle">11</td>
            </tr>
            <tr>
              <td align="center" valign="middle"><bold>5h</bold></td>
              <td align="center" valign="middle">-</td>
              <td align="center" valign="middle">11</td>
              <td align="center" valign="middle">-</td>
              <td align="center" valign="middle">-</td>
              <td align="center" valign="middle">-</td>
            </tr>
            <tr>
              <td align="center" valign="middle"><bold>5j</bold></td>
              <td align="center" valign="middle">-</td>
              <td align="center" valign="middle">-</td>
              <td align="center" valign="middle">-</td>
              <td align="center" valign="middle">-</td>
              <td align="center" valign="middle">-</td>
            </tr>
            <tr>
              <td align="center" valign="middle"><bold>S.10</bold></td>
              <td align="center" valign="middle">17</td>
              <td align="center" valign="middle">17</td>
              <td align="center" valign="middle">16</td>
              <td align="center" valign="middle">-</td>
              <td align="center" valign="middle">-</td>
            </tr>
            <tr>
              <td align="center" valign="middle"><bold>N.30</bold></td>
              <td align="center" valign="middle">-</td>
              <td align="center" valign="middle">-</td>
              <td align="center" valign="middle">-</td>
              <td align="center" valign="middle">-</td>
              <td align="center" valign="middle">18</td>
            </tr>
          </tbody>
        </table>
      <table-wrap-foot>
      <fn>
      <p>*For microbe species see Experimental; compound concentrations = 50 &#x3BC;g/disc; including disc diameter (6 mm); S.10: Streptomycin sulfate 10 &#x3BC;g/disc, N.30: Nystatin: 30 &#x3BC;g/disc. The symbol (-) means that the compounds had no activity against the microorganisms. </p>
	  </fn>
      </table-wrap-foot>
	  </table-wrap>
    </sec>
    <sec sec-type="methods">
      <title>Experimental</title>
      <sec>
        <title>General</title>
        <p>All the chemicals were purchased from Merck and used as received, except dichloroacteone and acetylbenzofuran, which were synthesized in our laboratory. Melting points were determined on a Thomas Hoover melting point apparatus and are uncorrected. The IR spectra were measured with Mattson 1000 FT-IR spectrophotometer. The <sup>1</sup>H-NMR spectra were recorded on a Varian-Gemini 200 MHz spectrometer and are reported in ppm (&#x3B4;) relative to tetramethylsilane (TMS) as the internal standard and <sup>13</sup>C-NMR spectra (50.34 MHz) are referenced to deuterochloroform (CDCl<sub>3</sub>). Elemental analyses were determined on a LECO CHNSO-932 auto elemental analysis apparatus. Analyses (TLC) were performed on precoated 0.2 mm Merck Kieselgel 60 F254 plates, visualizing with a 254 nm UV lamp. Column chromatography was performed using Merck silica gel, 70-230 mesh. Solvents were dried and purified by known conventional methods prior to use.</p>
      </sec>
      <sec>
        <title>General procedure for the synthesis of bisbenzofuran-2-yl-methanone <italic>(<bold>1</bold>)</italic>, method A.</title>
        <p>In a two necked 250 mL flask equipped with a reflux condenser, 2-acetylbenzofuran (16 g, 100 mmol) in acetic acid (150 mL) was heated to 50 &#x2DA;C. To this, bromine (16 g, 100 mmol) in acetic acid (50 mL) was added dropwise under nitrogen atmosphere and stirred at same temperature for 2 h while monitoring the course of the reaction by TLC. After cooling to room temperature, water was added. The solid, bromoacetylbenzofuran, thus separated was filtered off, washed with water several times and crystallized from ethanol. In the second stage, a mixture of salicylaldehyde (0.8 g, 3.34 mmol) and sodium hydride (0.08 g, 3.34 mmol) in acetone (50 mL) was stirred for 1h at room temperature. To this solution, a solution of bromoacetylbenzofuran (0.8 g, 3.34 mmol) in acetone (20 mL) was added dropwise and stirred for 18 h at room temperature. The solid <bold>1</bold> thus separated was filtered off, washed with water several times and crystallized from ethanol.</p>
      </sec>
      <sec>
        <title>General procedure for the synthesis of bisbenzofuran-2-yl-methanone <italic>(<bold>1</bold>)</italic>, method B.</title>
        <p>In a two necked 500 mL flask, a mixture of salicylaldehyde (61.73 g, 0.51 mol) and K<sub>2</sub>CO<sub>3</sub> (104 g, 0.76 mol) in acetone (200 mL) was stirred so that a bulky salt was obtained. To this mixture, a solution of dichloroactone (32.1 g, 0.25 mol) in acetone was added at room temperature and the mixture was stirred for 2 h. while the course of reaction was monitored by TLC. After cooling to room temperature, the mixture was poured into water and the precipitate of <italic>bisbenzofuran-2-yl-methanone</italic> (<bold>1</bold>) formed was filtered off, washed with water several times and crystallized from ethanol<italic>.</italic> Yield: 54.3 g (81.93 %); m.p.: 174.2 &#x2DA;C; IR (KBr): 1631 cm<sup>-1</sup> (C=O); <sup>1</sup>H&#x2011;NMR (CDCl<sub>3</sub>) &#x3B4;: 7.35 (t, 2H, <italic>j</italic>H<sub>3</sub>-H<sub>2</sub> = 7.33 Hz, <italic>j</italic>H<sub>3</sub>-H<sub>4</sub> = 7.33 Hz, H<sub>3</sub> aromatics ), 7.52 (t, 2H, H<sub>4</sub> aromatics which has same signals with H<sub>3</sub>, aromatics), 7.66 (d, 2H, <italic>j</italic>H<sub>5</sub>-H<sub>4</sub> = 7.11 Hz, H<sub>5</sub> aromatics), 7.78 (d, 2H, <italic>j</italic>H<sub>2</sub>-H<sub>3</sub> = 7.33 Hz, H<sub>2</sub> aromatics ), 8.02 (d, 2H, <italic>j</italic>H<sub>1</sub>-H<sub>2</sub> = 1.1 Hz, may be <italic>j</italic>H<sub>1</sub>-H<sub>5</sub> = 1.1 Hz, H<sub>1</sub> aromatics); <sup>13</sup>C&#x2011;NMR (CDCl<sub>3</sub>) &#x3B4;: 114.4, 118.2, 125.5, 126.11, 129.1, 130.6, 153.6, 157,8, 173.5 (C=O). Anal. Calcd. For C<sub>17</sub>H<sub>10</sub>O: C 77.85, H 3.84. Found: C 77.63, H 4.02.</p>
		<disp-formula>
		<inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molecules-10-01399-i001.tif"/>
		</disp-formula>
      </sec>
      <sec>
        <title>Synthesis of bisbenzofuran-2-yl-methanol <italic>(<bold>2</bold>)</italic>.</title>
        <p>In a two necked 25 mL flask equipped with a reflux condenser, a mixture of bisbenzofuran-2-yl-methanone (<bold>1</bold>, 2 g, 7.625 mmol) and NaBH<sub>4</sub> (0.29 g, 7.7 mmol) in dioxane (50 mL) was refluxed for 2 h. while the course of the reaction was monitored by IR. After cooling to room temperature, the mixture was poured into water and formed precipitate was filtered off by suction, dried in air and crystallized from ethanol. Yield: 1.83 g (91.5 %); m.p.: 91.7 &#x2DA;C; IR (KBr): 3230 cm<sup>-1</sup> (-OH); <sup>1</sup>H&#x2011;NMR (CDCl<sub>3</sub>) &#x3B4;: 3.02 (s, 1H, &gt;CH-), 6.11 (s, 1H, -OH), 6.79 (s, 2H, aromatics), 7.21-7.60 (m, 8H, aromatics); <sup>13</sup>C&#x2011;NMR (CDCl<sub>3</sub>) &#x3B4;: 157.2, 157.1, 129.9, 128.7, 125.1, 123.4, 113.5, 106.8, 67.1. Anal. Calcd. For C<sub>17</sub>H<sub>12</sub>O<sub>3</sub>: C 77.26, H 4.58. Found: C 76.89, H 4.61.</p>
      </sec>
      <sec>
        <title>General procedure for the synthesis of semicarbazones/thiosemicarbazones <italic><bold>3a</bold></italic> and <italic><bold>3b</bold></italic>.</title>
        <p>The preparation of <bold>3b</bold> is given as an example. A mixture of <bold>1</bold> (1 g, 4 mmol), thiosemicarbazide (0.365 g, 4 mmol) and <italic>p-</italic>toluenesulphonic acid (0.005 g, as catalyst) in absolute ethanol (50 mL) was refluxed. The course of the reaction was monitored by TLC. After the solvent was removed under reduced pressure, the residue was treated with water and solid product <bold>3b</bold> thus obtained was recrystallized from ethanol.</p>
        <p><italic>Bisbenzofuran-2-yl-methanone semicarbazone</italic> (<bold>3a</bold>). Yield: 1.09 g (89.64 %); m.p.: 189.4 &#x2DA;C; IR (KBr): 3467 cm<sup>-1</sup> (-NH<sub>2</sub>), 3286 cm<sup>-1</sup> (-NH-), 1738 cm<sup>-1</sup> (C=O), 1587 cm<sup>-1</sup> (C=N); <sup>1</sup>H&#x2011;NMR (CDCl<sub>3</sub>) &#x3B4;: 1.67 (s, 1H, -NH-), 6.57 (s, 1H, -NH-), 7.21-7.75 (m, 10H, aromatics), 10.73 (s, 1H, -NH- ), <sup>13</sup>C&#x2011;NMR (CDCl<sub>3</sub>) &#x3B4;: 181.4, 157.3, 156.9, 148.3, 130.8, 126.5, 125.6, 123.8, 114.1, 111.7. Anal. Calcd. For C<sub>18</sub>H<sub>13</sub>N<sub>3</sub>O<sub>3</sub>: C 67.71, H 4.10, N 13.16. Found: C 68.04, H 4.04, N 13.08.</p>
        <p><italic>Bisbenzofuran-2-yl-methanone thiosemicarbazone</italic> (<bold>3b</bold>). Yield: 0.53 g (41.73 %); m.p.: 194 &#x2DA;C; IR (KBr): 3399 and 3351 cm<sup>-1</sup> (-NH<sub>2</sub>), 3249 cm<sup>-1</sup> (-NH-), 1592 cm<sup>-1</sup> (C=N), 1077 (C=S); <sup>1</sup>H&#x2011;NMR (CDCl<sub>3</sub>) &#x3B4;: 7.1 (s, 1H, -NH-), 7.2-7.7 (m, 11H, aromatics plus -NH-), 9.8 (s, 1H, -NH-); <sup>13</sup>C&#x2011;NMR (CDCl<sub>3</sub>) &#x3B4;: 178.4, 158.4, 157.1, 156.7, 131.5, 126.3, 125.7, 123.9, 113.7, 111.4. Anal. Calcd. For C<sub>18</sub>H<sub>13</sub>N<sub>3</sub>O<sub>2</sub>S: C 64.46, H 3.91, N 12.53, S 9.56. Found: C 64.27, H 4.03, N 12.66, S 9.91.</p>
      </sec>
      <sec>
        <title>General procedure for the synthesis of ketoxime <italic><bold>4</bold></italic>.</title>
        <p>Compound <bold>1</bold> (20 g, 76 mmol), hydroxylamine hydrochloride (5.56 g, 80 mmol) and pyridine (100 mL) were mixed. The mixture was refluxed to complete the reaction while monitoring its course by IR. After cooling to room temperature, the mixture was poured into water. The solid <italic>bis-benzofuran-2-yl-methanone oxime</italic> (<bold>4</bold>) thus separated was filtered off, washed with water several times and crystallized from ethanol. Yield: 20.75 g (98.15 %); m.p.: 230.9 &#x2DA;C; IR (KBr): 3166 cm<sup>-1</sup> (-OH oxime), 1581 cm<sup>-1</sup> (C=N), 1036 (N-O); <sup>1</sup>H&#x2011;NMR (CDCl<sub>3</sub>) &#x3B4;: 13.01 (br s, 1H, -OH), 7.25-7.94 (m, 10H, aromatics), <sup>13</sup>C&#x2011;NMR (CDCl<sub>3</sub>) &#x3B4;: 155.9, 154.8, 145.9, 135.8, 128.6, 127.4, 125.1, 123.6, 110.4. Anal. Calcd. For C<sub>17</sub>H<sub>11</sub>NO<sub>3</sub>: C 73.64, H 4.00, N 5.05. Found: C 73.55, H 4.06, N 5.11.</p>
      </sec>
      <sec>
        <title>General procedure for the synthesis of oxime-ethers <italic><bold>5a-h</bold></italic>.</title>
        <p>Compound <bold>4</bold> (1.0 g, 3.6 mmol), K<sub>2</sub>CO<sub>3</sub> (0.55 g, 4 mmol) and an appropriate alkyl halogenide or acid chloride (3.6 mmol) were mixed in absolute acetone. The mixture was refluxed to complete the reaction while monitoring its course by IR. After cooling to room temperature, the mixture was poured into water. The solid thus separated was filtered off, washed with copious water and recrystallized from ethanol.</p>
        <p><italic>Bisbenzofuran-2-yl-methanone O-methyl oxime</italic> (<bold>5a</bold>). Yield: 0.43 g (41.03 %); m.p.: 131.0 &#x2DA;C; IR (KBr): 2937 cm<sup>-1</sup> (-CH<sub>3</sub> aliphatics), 1613 cm<sup>-1</sup> (C=N); <sup>1</sup>H&#x2011;NMR (CDCl<sub>3</sub>) &#x3B4;: 4.30 (s, 3H, -CH<sub>3</sub>), 7.18-7.77 (m, 10H, aromatics). <sup>13</sup>C&#x2011;NMR (CDCl<sub>3</sub>) &#x3B4;: 156.9, 155.7, 148.3, 141.0, 130.2, 128.5, 127.8, 123.9, 113.8, 54.4. Anal. Calcd. For C<sub>18</sub>H<sub>13</sub>NO<sub>3</sub>: C 74.22, H 4.50, N 4.81. Found: C 73.89, H 4.61, N 5.02.</p>
        <p><italic>Bisbenzofuran-2-yl-methanone O-benzyl oxime</italic> (<bold>5b</bold>). Yield: 1.87 g (70.56 %); m.p.: 127.6 &#x2DA;C; IR (KBr): 2936 cm<sup>-1</sup> (-CH<sub>3</sub>, aliphatics), 1614 cm<sup>-1</sup> (C=N), 1004 (N-O); <sup>1</sup>H&#x2011;NMR (CDCl<sub>3</sub>) &#x3B4;: 5.56 (s, 2H, -CH<sub>2</sub>-), 7.26-7.76 (m, 10H, aromatics). <sup>13</sup>C&#x2011;NMR (CDCl<sub>3</sub>) &#x3B4;: 156.9, 155.7, 150.9, 148.4, 138.8, 130.3, 129.8, 127.7, 125.2, 123.7, 113.6, 80.5. Anal. Calcd. For C<sub>24</sub>H<sub>17</sub>NO<sub>3</sub>: C 78.46, H 4.66, N 3.81. Found: C 78.44, H 4.75, N 3.94. </p>
        <p><italic>Bisbenzofuran-2-yl-methanone O-oxiranylmethyl oxime</italic> (<bold>5c</bold>). Yield: 0.52 g (21.66 %); m.p.: 88.4 &#x2DA;C; IR (KBr): 2930 cm<sup>-1</sup> (-CH<sub>2</sub>-, aliphatics), 1613 cm<sup>-1</sup> (C=N), 1259 cm<sup>-1</sup> (C-O, on benzofuran ring),  1046 cm<sup>-1</sup> (C-O, epoxide), 1014 (N-O); <sup>1</sup>H&#x2011;NMR (CDCl<sub>3</sub>): <sup>&#x3B4;</sup>H<sub>D</sub>, 2.76 (dd, 1H, <italic>j</italic><sub>DC</sub> = 5.3 Hz, <italic>j</italic><sub>DB</sub> = 2.6 Hz),  <sup>&#x3B4;</sup>H<sub>C</sub>, 2.85 (dd, 1H, <italic>j</italic><sub>CB</sub> = 4.8 Hz, <italic>j</italic><sub>CD</sub> = 5.3 Hz), <sup>&#x3B4;</sup>B, 3.47 (m, 1H, H<sub>B</sub>), <sup>&#x3B4;</sup>H<sub>E</sub>, 4.41 (dd, 1H, <italic>j</italic><sub>AE</sub> = 12.2 Hz, <italic>j</italic><sub>BE</sub> = 6.4 Hz),   <sup>&#x3B4;</sup>H<sub>A</sub>, 4.77 (dd, 1H, <italic>j</italic><sub>AB</sub> = 2.8 Hz, <italic>j</italic><sub>AE</sub> = 12.2 Hz), ), 7.25-7.83 (m, 10H, aromatics). <sup>13</sup>C&#x2011;NMR (CDCl<sub>3</sub>) &#x3B4;: 156.9, 155.8, 146.1, 130.1, 127.8, 125.2, 123.7, 113.7, 78.4, 52.1, 46.8. Anal. Calcd. For C<sub>20</sub>H<sub>15</sub>NO<sub>4</sub>: C 72.06, H 4.54, N 4.20. Found: C 71.96, H 4.49, N 4.17. </p>
		<disp-formula>
		<inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molecules-10-01399-i002.tif"/>
		</disp-formula>
        <p><italic>Bisbenzofuran-2-yl-methanone O-benzoyl oxime</italic> (<bold>5d</bold>). Yield: 1.29 g (94.16 %); m.p.: 154.9 &#x2DA;C; IR (KBr): 1747 cm<sup>-1</sup> (C=O), 1612 cm<sup>-1</sup> (C=N), 1057 (N-O); <sup>1</sup>H&#x2011;NMR (CDCl<sub>3</sub>) &#x3B4;: 7.28-7.79 (m, 13H, aromatics), 8.18-21 (m, 2H, aromatics); <sup>13</sup>C&#x2011;NMR (CDCl<sub>3</sub>) &#x3B4;: 165.4, 157.7, 156.9, 149.8, 146.1, 132.0, 130.8, 129.4, 128.5, 125.9, 125.5, 124.6, 124.1, 113.9. Anal. Calcd. For C<sub>24</sub>H<sub>15</sub>NO<sub>4</sub>: C 75.58, H 3.96, N 3.67. Found: C 75.43, H 4.02, N 3.88.</p>
        <p><italic>(Bis-benzofuran-2-yl-methyleneaminooxy)-acetic acetic acid ethyl ester</italic> (<bold>5e</bold>). Yield: 5.87 g (98.62 %); m.p.: 116.7 &#x2DA;C; IR (KBr): 2977 cm<sup>-1</sup> (aliphatics), 1755 cm<sup>-1</sup> (C=O), 1614 cm<sup>-1</sup> (C=N), 1033 cm<sup>&#x2011;1</sup> (N-O), 1087 cm<sup>-1</sup> (C-O); <sup>1</sup>H&#x2011;NMR (CDCl<sub>3</sub>) &#x3B4;: 1.34 (t, 3H, <italic>j</italic>=7.21. &#x2013;CH<sub>3</sub>), 4.31 (q, <italic>j</italic>=7.05, 2H, &#x2011;CH<sub>2</sub>-), 5.05 (s, 2H, -CH<sub>2</sub>-), 7.27-7.74 (m, 10H, aromatics); <sup>13</sup>C&#x2011;NMR (CDCl<sub>3</sub>) &#x3B4;: 171.0, 157.0, 155.9, 145.9, 130.0, 128.6, 125.2, 124.4, 123.8, 113.7, 74.4, 63.2, 16.2. Anal. Calcd. For C<sub>21</sub>H<sub>17</sub>NO<sub>5</sub>: C 69.41, H 4.72, N 3.85. Found: C 69.55, H 4.87, N 4.01.</p>
        <p><italic>Bis-benzofuran-2-yl-methanone O-(2-phenylacetyl) oxime</italic> (<bold>5f</bold>). Yield: 1.28 g (89.95 %); m.p.: 141.4 &#x2DA;C; IR (KBr): 2919 cm-1 (aliphatics), 1753 cm<sup>-1</sup> (C=O), 1613 cm<sup>-1</sup> (C=N), 1021 (N-O), 1260 (C-O, on furan ring); <sup>1</sup>H&#x2011;NMR (CDCl<sub>3</sub>) &#x3B4;: 3.99 (s, 2H, &#x2013;CH<sub>2</sub>-), 7.05-7.70 (m, 15H, aromatics); <sup>13</sup>C&#x2011;NMR (CDCl<sub>3</sub>) &#x3B4;: 169.9, 157.4, 156.3, 147.4, 134.9, 130.9, 129.6, 128.9, 125.5, 124.0, 118.5, 114.5, 113.0, 42.6. Anal. Calcd. For C<sub>25</sub>H<sub>17</sub>NO<sub>4</sub>: C 75.94, H 4.33, N 3.54. Found: C 76.12, H 4.46, N 3.43.</p>
        <p><italic>Bis-benzofuran-2-yl-methanone O-(2-chloroacetyl) oxime</italic> (<bold>5g</bold>). Yield: 1.18 g (92.69 %); m.p.: 135 &#x2DA;C; IR (KBr): 2954 cm<sup>-1</sup> (aliphatics), 1785 cm<sup>-1</sup> (C=O), 1613 cm<sup>-1</sup> (C=N), 1012 (N-O), 1221 (C-O, on furan ring), 747 cm<sup>-1</sup> (-CH<sub>2</sub>-Cl); <sup>1</sup>H&#x2011;NMR (CDCl<sub>3</sub>) &#x3B4;: 4.43 (s, 2H, &#x2013;CH<sub>2</sub>-), 7.26-7.81 (m, 10H, aromatics); <sup>13</sup>C&#x2011;NMR (CDCl<sub>3</sub>) &#x3B4;: 166.8, 157.6, 144.9, 129.7, 129.0, 128.8, 125.6, 124.7, 124.2, 113.9, 42.1. Anal. Calcd. For C<sub>19</sub>H<sub>12</sub>ClNO<sub>4</sub>: C 64.51, H 3.42, N 3.96. Found: C 64.68, H 3.37, N 3.74.</p>
        <p><italic>Bis-benzofuran-2-yl-methanone O-acetyl oxime</italic> (<bold>5h</bold>). Yield: 1.18 g (95.65%); m.p.: 95.2 &#x2DA;C; IR (KBr): 2931 cm<sup>-1</sup> (aliphatics), 1780 cm<sup>-1</sup> (C=O), 1613 cm<sup>-1</sup> (C=N), 1256 cm<sup>-1</sup> (C-O, on benzofuran ring), 1021 cm<sup>-1</sup> (N-O),; <sup>1</sup>H&#x2011;NMR (CDCl<sub>3</sub>) &#x3B4;: 2.40 (s, 3H, &#x2013;CH<sub>3</sub>), 7.29-7.77 (m, 10H, aromatics); <sup>13</sup>C&#x2011;NMR (CDCl<sub>3</sub>) &#x3B4;: 169.9, 157.5, 156.4, 145.4, 129.4, 128.3, 125.5, 124.4, 118.2, 113.9, 21.8. Anal. Calcd. For C<sub>18</sub>H<sub>13</sub>N<sub>3</sub>O<sub>2</sub>S: C 71.47, H 4.10, N 4.39. Found: C 71.57, H 4.03, N 4.25.</p>
      </sec>
      <sec>
        <title>General procedure for the synthesis of <italic><bold>5i</bold></italic>.</title>
        <p>Compound <bold>5e</bold> (1.5 g, 4.13 mmol) and NaOH (0.32 g, 8 mmol) in EtOH (50 mL) were mixed. The mixture was refluxed to complete the reaction while monitoring its course by IR. After cooling to room temperature, the mixture was poured into water. Acidified with 5% HCl (pH = 3-4). The solid <italic>(bis-benzofuran&#x2013;2-yl-methyleneaminooxy) acetic acid</italic> (<bold>5i</bold>) thus separated was filtered off, washed with water several times and crystallized from ethanol. Yield: 1.23 g (89.13 %); m.p.: 176.2 &#x2DA;C; IR (KBr): 2924 cm<sup>-1</sup> (aliphatics), 1701 cm<sup>-1</sup> (C=O), 1614 cm<sup>-1</sup> (C=N), 1039 cm<sup>-1</sup> (N-O), 1006 cm<sup>-1</sup> (C-O); <sup>1</sup>H&#x2011;NMR (CDCl<sub>3</sub>) &#x3B4;: 5.18 (s, 2H, &#x2013;CH<sub>2</sub>-), 7.24-7.75 (m, 10H, aromatics), 8.43 (br s, 1H, -OH); <sup>13</sup>C&#x2011;NMR (CDCl<sub>3</sub>) &#x3B4;: 176.0, 157.0, 145.9, 142.9, 130.0, 128.7, 128.0, 125.3, 123.9, 113.7, 73.9. Anal. Calcd. For C<sub>19</sub>H<sub>13</sub>NO<sub>5</sub>: C 68.06, H 3.91, N 4.18. Found: C 68.17, H 4.02, N 4.22.</p>
      </sec>
      <sec>
        <title>General procedure for the synthesis of <italic><bold>5j</bold></italic>.</title>
        <p>The mixture of compound <bold>5e</bold> (1.5 g, 4.13 mmol) and NH<sub>2</sub>NH<sub>2</sub>&#x387;H<sub>2</sub>O (0.25 g, 5 mmol) in absolute EtOH (50 mL) was refluxed for 8 h. to complete the reaction while monitoring its course by IR. After cooling to room temperature, the mixture was poured into cold water. The solid <italic>(bis-benzofuran-2-yl-methleneaminooxy) acetic acid hydrazide</italic> (<bold>5j</bold>) thus separated was filtered off, washed with water several times and crystallized from ethanol. Yield: 1.08 g (75.00 %); m.p.: 198 &#x2DA;C; IR (KBr): 3334-3314 cm<sup>-1</sup> (-NH<sub>2</sub> and &#x2013;NH-), 2940 cm<sup>-1</sup> (aliphatics), 1660 cm<sup>-1</sup> (C=N), 1030 cm<sup>-1</sup> (N-O), 949 cm<sup>-1</sup> (C-O); <sup>1</sup>H&#x2011;NMR (CDCl<sub>3</sub>) &#x3B4;: 4.40 (br s, 2H, &#x2013;NH<sub>2</sub>), 4.85 (s, 2H, -CH<sub>2</sub>-), 7.34-7.88 (m, 10H, aromatics), 9.34 (s, 1H, -NH-); <sup>13</sup>C&#x2011;NMR (CDCl<sub>3</sub>) &#x3B4;: 168.7, 156.0, 155.1, 149.8, 145.2, 129.4, 128.8, 125.6, 123.9, 113.6, 75.2. Anal. Calcd. For C<sub>19</sub>H<sub>15</sub>N<sub>3</sub>O<sub>4</sub>: C 65.32, H 4.33, N 12.03. Found: C 65.47, H 4.42, N 12.16.</p>
      </sec>
    <sec>
      <title>Preparation of microbial cultures and biological assays</title>
      <p>Microorganisms were obtained from the culture collection of the Microbiology Laboratory of the Biological Sciences of Faculty of Science and Arts, Firat University, Turkey. In this work, <italic>Bacillus subtilis</italic> LM 622 (B.s.), <italic>Enterobacter aeruginosa</italic> CCM 2531 (E.a.), <italic>Eschericia coli</italic> ATCC 25922 (E.c.), <italic>Listeria monocytogenes</italic> SCOTTA (L.m.), <italic>Pseudomonas aeruginosa</italic> DSM 50071 (P.a.), <italic>Staphilococcus aureus</italic> COWAN I (S.a.) <italic>Candida albicans</italic> FMC 17 (C.a.) and <italic>Saccharamyces cerevisiae</italic> FMC 16 (S.c.) were used to investigate the bacteriological and antifungal activities of selected substances.</p>
      <p>The bacteria and yeast strains were nourished in nutrient broth (Difco) and in malt extract broth (Difco), and incubated for 24 and 48 h, respectively. In the Disk Diffusion method, the sterile Mueller Hinton Agar (Oxoid) for bacteria and Saburoud Dextrose Agar for yeast were separately inoculated with the test microorganisms. The compounds, dissolved in DMSO as 500 &#xB5;g/disc solutions, were placed in 6 mm wells in the agar media and the plates were incubated at 32 &#xB0;C for bacteria (18-24 h) and at 25&#xB0; C for yeast (72 h) [<xref ref-type="bibr" rid="B15-molecules-10-01399">15</xref>]. The resulting inhibition zones on the plates were measured (in mm) after 48 h (<xref ref-type="table" rid="molecules-10-01399-t001">Table 1</xref>). The control samples were only dissolved in DMSO. The data reported in <xref ref-type="table" rid="molecules-10-01399-t001">Table 1</xref> are the average of three experiments.</p>
    </sec>
	</sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgments</title>
      <p>We are indebted to Firat University Research Foundation (FUBAP, project No: 866) for financial support of this work.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="B1-molecules-10-01399">
        <label>1.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Thakar</surname>
              <given-names>K.A.</given-names>
            </name>
            <name>
              <surname>Dumir</surname>
              <given-names>A.B.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis of Benzofuran Analogs of Disodium-Cromoglycate. 3. Synthesis of Bis(Benzofuran-6-Oxy) Alkanes</article-title>
          <source>Indian J. Chem. Sect. B-Org. Chem. Med. Chem.</source>
          <year>1977</year>
          <volume>15</volume>
          <fpage>1053</fpage>
          <lpage>1054</lpage>
        </citation>
      </ref>
      <ref id="B2-molecules-10-01399">
        <label>2.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cairns</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Fitzmaurice</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Hunter</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>P.B.</given-names>
            </name>
            <name>
              <surname>King</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>T. B.</given-names>
            </name>
            <name>
              <surname>Lord</surname>
              <given-names>G.H.</given-names>
            </name>
            <name>
              <surname>Minshull</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Cox</surname>
              <given-names>J.S.G.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and Structure-Activity Relations of Disodium Cromoglycate and Some Related Compounds</article-title>
          <source>J. Med. Chem.</source>
          <year>1972</year>
          <volume>15</volume>
          <fpage>583</fpage>
          <lpage>589</lpage>
        </citation>
      </ref>
      <ref id="B3-molecules-10-01399">
        <label>3.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hall</surname>
              <given-names>C.M.</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>H.G.</given-names>
            </name>
            <name>
              <surname>Wright</surname>
              <given-names>J.B.</given-names>
            </name>
          </person-group>
          <article-title>Quinoline Derivatives as Antiallergy Agents</article-title>
          <source>J. Med. Chem.</source>
          <year>1974</year>
		  <volume>17</volume>
          <fpage>685</fpage>
          <lpage>690</lpage>
          <pub-id pub-id-type="doi">10.1021/jm00253a006</pub-id>
        </citation>
      </ref>
      <ref id="B4-molecules-10-01399">
        <label>4.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sunder</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Peet</surname>
              <given-names>N.P.</given-names>
            </name>
          </person-group>
          <article-title>Preparation of a DSCG-Like Bisbenzofuran</article-title>
          <source>J. Heterocycl. Chem.</source>
          <year>1980</year>
          <volume>17</volume>
          <fpage>1117</fpage>
          <lpage>1118</lpage>
          <pub-id pub-id-type="doi">10.1002/jhet.5570170557</pub-id>
        </citation>
      </ref>
      <ref id="B5-molecules-10-01399">
        <label>5.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Witiak</surname>
              <given-names>D.T.</given-names>
            </name>
            <name>
              <surname>Newman</surname>
              <given-names>H.A.I.</given-names>
            </name>
            <name>
              <surname>Poochikian</surname>
              <given-names>G.K.</given-names>
            </name>
            <name>
              <surname>Fogt</surname>
              <given-names>S.W.</given-names>
            </name>
            <name>
              <surname>Baldwin</surname>
              <given-names>J.R.</given-names>
            </name>
            <name>
              <surname>Sober</surname>
              <given-names>C.L.</given-names>
            </name>
            <name>
              <surname>Feller</surname>
              <given-names>D.R.</given-names>
            </name>
          </person-group>
          <article-title>Diethyl (4b&#x3B1;,4c&#x3B1;,9a&#x3B1;,9b&#x3B1;)-3,6-dichlorocyclobuta[1,2-b:3,4-b']bis-benzofuran-9a,9b (4bH, 4cH)-dicarboxylate: the cis, syn photodimer of ethyl 5-chlorobenzofuran-2-carboxylate, an analog related to the antilipidemic drug clofibrate</article-title>
          <source>J. Med. Chem.</source>
          <year>1978</year>
		  <volume>21</volume>
          <fpage>833</fpage>
          <lpage>837</lpage>
          <pub-id pub-id-type="doi">10.1021/jm00206a026</pub-id>
        </citation>
      </ref>
      <ref id="B6-molecules-10-01399">
        <label>6.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ionkin</surname>
              <given-names>A. S.</given-names>
            </name>
            <name>
              <surname>Marshall</surname>
              <given-names>W.J.</given-names>
            </name>
          </person-group>
          <article-title><italic>ortho</italic>-5-Methylfuran- and Benzofuran-Substituted &#x3B7;<sup>3</sup>-Allyl(&#x3B1;-diimine)nickel(II) Complexes: Syntheses, Structural Characterization, and the First Polymerization Results</article-title>
          <source>Organometallics</source>
          <year>2004</year>
		  <volume>23</volume>
          <fpage>3276</fpage>
          <lpage>3283</lpage>
          <pub-id pub-id-type="doi">10.1021/om0497902</pub-id>
        </citation>
      </ref>
      <ref id="B7-molecules-10-01399">
        <label>7.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bergman</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Egestad</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Rajapaksa</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>X-Ray Crystal and Molecular-Structure Determination of A Benzo[1,2-B-4,5-B']Bisbenzofuran Derivative Formed By Base-Induced Condensation of 3(2h)-Benzofuranone</article-title>
          <source>Acta Chem. Scand. Ser. B-Org. Chem. Biochem.</source>
          <year>1979</year>
          <volume>33</volume>
          <fpage>405</fpage>
          <lpage>409</lpage>
        </citation>
      </ref>
      <ref id="B8-molecules-10-01399">
        <label>8.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dijk</surname>
              <given-names>J.V.</given-names>
            </name>
            <name>
              <surname>Zwagemakers</surname>
              <given-names>J.M.A.</given-names>
            </name>
          </person-group>
          <article-title>Oxime Ether Derivatives, A New Class of Nonsteroidal Antiinflammatory Compounds</article-title>
          <source>J. Med. Chem.</source>
          <year>1977</year>
          <volume>20</volume>
          <fpage>1199</fpage>
          <lpage>1206</lpage>
        </citation>
      </ref>
      <ref id="B9-molecules-10-01399">
        <label>9.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fravolini</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Schiaffella</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Orzalesi</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Selleri</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Volpato</surname>
              <given-names>I.</given-names>
            </name>
          </person-group>
          <article-title>Oxime Ether Derivatives of Thiochroman-4-Ones as Beta-Adrenergic Blocking-Agents</article-title>
          <source>Eur. J. Med. Chem.</source>
          <year>1978</year>
          <volume>13</volume>
          <fpage>347</fpage>
          <lpage>350</lpage>
        </citation>
      </ref>
      <ref id="B10-molecules-10-01399">
        <label>10.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Burditt</surname>
              <given-names>S.J.</given-names>
            </name>
            <name>
              <surname>Hamilton</surname>
              <given-names>P.B.</given-names>
            </name>
          </person-group>
          <article-title>Mold Inh&#x131;bitory Activity of an N-Oxime Ether</article-title>
          <source>Poultry Sci.</source>
          <year>1983</year>
		  <volume>62</volume>
          <fpage>2183</fpage>
          <lpage>2186</lpage>
          <pub-id pub-id-type="doi">10.3382/ps.0622183</pub-id>
        </citation>
      </ref>
      <ref id="B11-molecules-10-01399">
        <label>11.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Delmas</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Gasquet</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Timondavid</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Madadi</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Vanelle</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Vaille</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Maldonado</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and Invitro Anti-Protozoan Activity of New 5-Nitrothiophene Oxime Ether Derivatives</article-title>
          <source>Eur. J. Med. Chem.</source>
          <year>1993</year>
		  <volume>28</volume>
          <fpage>23</fpage>
          <lpage>27</lpage>
          <pub-id pub-id-type="doi">10.1016/0223-5234(93)90075-P</pub-id>
        </citation>
      </ref>
      <ref id="B12-molecules-10-01399">
        <label>12.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chowdhury</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Saxean</surname>
              <given-names>V.S.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and Insect Growth Regulatory Activity of Alkoxy-Substituted Benzaldoxime Ethers</article-title>
          <source>J. Agr. Food Chem.</source>
          <year>1998</year>
		  <volume>36</volume>
          <fpage>731</fpage>
          <lpage>736</lpage>
          <pub-id pub-id-type="doi">10.1021/jf970062h</pub-id>
        </citation>
      </ref>
      <ref id="B13-molecules-10-01399">
        <label>13.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jindal</surname>
              <given-names>D.P.</given-names>
            </name>
            <name>
              <surname>Chattopadhaya</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Guleria</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Gupta</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and Antineoplastic Activity of 2-Alkylaminoethyl Derivatives of Various Steroidal Oximes</article-title>
          <source>Eur. J. Med. Chem.</source>
          <year>2003</year>
		  <volume>38</volume>
          <fpage>1025</fpage>
          <lpage>1034</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ejmech.2003.09.002</pub-id>
        </citation>
      </ref>
      <ref id="B14-molecules-10-01399">
        <label>14.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Davtyan</surname>
              <given-names>G.L.</given-names>
            </name>
            <name>
              <surname>Papayan</surname>
              <given-names>S.M.</given-names>
            </name>
          </person-group>
          <article-title>2,2-Dibenzofuryl Ketone</article-title>
          <source>Khim. Geterosikl. Soedin.</source>
          <year>1979</year>
          <volume>11</volume>
          <fpage>57</fpage>
          <lpage>58</lpage>
		  <comment>(in Russian); [<italic>Chem. Abstr.</italic> <bold>1981</bold>, <italic>94</italic>, 15464u]</comment>
        </citation>
      </ref>
      <ref id="B15-molecules-10-01399">
        <label>15.</label>
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Collins</surname>
              <given-names>C.H.</given-names>
            </name>
            <name>
              <surname>Lyne</surname>
              <given-names>P.M.</given-names>
            </name>
            <name>
              <surname>Granga</surname>
              <given-names>J.M.</given-names>
            </name>
          </person-group>
          <source>Microbiological Methods</source>
          <edition>6th Ed.</edition>
          <publisher-name>Butterworths Co. Ltd.</publisher-name>
          <publisher-loc>London</publisher-loc>
          <year>1989</year>
          <fpage>410</fpage>
        </citation>
      </ref>
    </ref-list>
	<fn-group>
    <fn>
	<p><italic>Sample availability:</italic> Available from the authors. Some compounds (<bold>1</bold>, <bold>2</bold>, <bold>5a</bold>, <bold>5d</bold>, and <bold>5g</bold>) are available from MDPI</p>
	</fn>
    </fn-group>
  </back>
</article>
